XERIS BIOPHARMA HOLDINGS INC

Ticker: XERS CUSIP: 98422E103 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 1,058,692 Value ($000) $8,311 Avg Close $7.87 Range $6.47 - $10.08

Q3 2025

Shares 1,698,757 Value ($000) $13,828 Avg Close $6.64 Range $4.52 - $8.35

Q2 2025

Shares 1,227,959 Value ($000) $5,735 Avg Close $4.58 Range $3.81 - $5.50

Q1 2025

Shares 589,471 Value ($000) $3,236 Avg Close $4.04 Range $3.14 - $6.07

Q4 2024

Shares 171,332 Value ($000) $581 Avg Close $3.22 Range $2.69 - $3.87

Q3 2024

Shares 83,108 Value ($000) $237 Avg Close $2.57 Range $2.03 - $3.04

Q1 2022

Shares 28,897 Value ($000) $74 Avg Close $2.44 Range $1.94 - $3.10

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	1,058,692	$8,311	$7.87	$6.47 - $10.08
Q3 2025	1,698,757	$13,828	$6.64	$4.52 - $8.35
Q2 2025	1,227,959	$5,735	$4.58	$3.81 - $5.50
Q1 2025	589,471	$3,236	$4.04	$3.14 - $6.07
Q4 2024	171,332	$581	$3.22	$2.69 - $3.87
Q3 2024	83,108	$237	$2.57	$2.03 - $3.04
Q1 2022	28,897	$74	$2.44	$1.94 - $3.10